EP1853293
THYMOSIN BETA 4 FOR TREATING MULTIPLE SCLEROSIS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
13.1.2006EP published:
21.12.2016EP application number:
06718342.6
EPO information:
European Patent Register
Max expiry date:
12.1.2026
Title:
THYMOSIN BETA 4 FOR TREATING MULTIPLE SCLEROSIS
Timeline
Today
13.1.2006EP application
21.12.2016EP Publication
Owner
Name:
Regenerx Biopharmaceuticals, Inc.Address:
3 Bethesda Metro Center, Suite 630, 20814, Bethesda, Maryland, US
Inventor
Name:
GOLDSTEIN, Allan L.Address:
Washington, District Of Columbia, US
Name:
FINKELSTEIN, Jack, Jr.Address:
Chevy Chase, Maryland, US
Priority
Number:
643307 PDate:
13.1.2005Country:
US
Classification
Categories:
A61K 38/08, A61K 38/17, A61K 38/18, A61K 38/19, A61K 38/20, A61K 38/21, A61K 38/22, G01N 33/50